3min chapter

The Intelligence from The Economist cover image

Ready, steady, slow: Ukraine’s bid for Kherson

The Intelligence from The Economist

CHAPTER

We're Not Using the Synthetic Alternative

The fda makes it really hard for companies to get drugs approve that aren't in the us p manual. The only method th t they've approved is l a l and they have not adopted the synthetic version. It's going to be very difficult for pharma seutical companies to get truds approved. And meanwhile, things get even more difficult for the horseshoe crabs themselves.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode